• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » FDA OKs edible sensor “pill” under new device category | MassDevice.com On Call

FDA OKs edible sensor “pill” under new device category | MassDevice.com On Call

July 31, 2012 By MassDevice staff

MassDevice On Call

MASSDEVICE ON CALL — The FDA handed Proteus Digital Health clearance for its novel ingestible sensor, passing the product through a new medical device category.

The sensor is swallowed in a pill and powered through contact with stomach fluids. The device communicates wirelessly with a patch on the skin, which collects metrics such as heart rate, body position and activity.

The patch then relays the data to a mobile phone application, which can make the information accessible to family, caregivers and clinicians, according to a press release.

"The FDA validation represents a major milestone in digital medicine," Scripps Research Institute genomics professor Dr. Eric Topol said in prepared remarks. "Directly digitizing pills, for the first time, in conjunction with our wireless infrastructure, may prove to be the new standard for influencing medication adherence and significantly aid chronic disease management."

 Heart CTs may provide faster, more accurate chest emergency assessment
Adding computer tomography scans to existing standards for emergency care may help healthcare providers more quickly diagnose heart attacks in patients complaining of chest pain.
Read more

 Dendreon cuts 600 jobs, closes plant as sales disappoint
Cancer immunotherapy products maker Dendreon will lay off 600 full-time contractors and shutter its Morris Plains, N.J., factory in hopes of saving $150 million a year in costs as the biotech products company’s sales slide.
Read more

 CareFusion updates on EnVe ventilator recall
Medical device company CareFusion provided an update on its recall of EnVe ventilators, which were pulled off of shelves over concerns that the devices may leak. The FDA dubbed the measure Class I, the most serious type of recall.
Read more

 10 milestones in spinal devices
Beckers Orthopedic & Spine highlights 10 important milestones in spinal devices and medical device companies, including Medtronic’s (NYSE:MDT) global launch of the expanded CD Horizon Solera 5.5/6.0 system and Precision Spine’s $72 million buyout of Precision Medical of Mississippi.  
Read more

Filed Under: 510(k), Food & Drug Administration (FDA), News Well, Recalls, Spine Tagged With: CareFusion Corp., Dendreon Corp., Layoffs, On Call

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy